Related Experiment Video
Updated: Jan 6, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Serum Albumin Level and In-Hospital Outcome of Patients with First Attack Acute Myocardial Infarction
M S Islam1, M N Islam, S K Kundu
1Dr Md Saiful Islam, MD Cardiology, Thesis Part Student, Mymensingh Medical College (MMC), Mymensingh, Bangladesh.
Insights
Low serum albumin levels in patients with first-time acute myocardial infarction (AMI) are linked to worse hospital outcomes. This finding highlights serum albumin as a potential risk indicator for adverse cardiac events in AMI patients.
Area of Science:
- Cardiology
- Clinical Biochemistry
Background:
- Acute myocardial infarction (AMI) is a leading cause of hospital admissions.
- Serum albumin levels may indicate cardiovascular disease risk and patient prognosis.
- Effective risk stratification is crucial for managing AMI patients.
Purpose of the Study:
- To evaluate the association between serum albumin levels upon admission and in-hospital adverse outcomes in patients experiencing their first acute myocardial infarction.
Main Methods:
- A cross-sectional analytical study involving 374 first-time AMI patients.
- Patients were categorized into two groups based on serum albumin levels: <3.5 gm/dL (Group I) and ≥3.5 gm/dL (Group II).
- Serum albumin was measured within 24 hours of admission, and major in-hospital cardiac outcomes were recorded.
Main Results:
- Group I patients (albumin <3.5 gm/dL) exhibited significantly higher rates of heart failure (59.80%), cardiogenic shock (8.00%), arrhythmias (11.50%), and mortality (9.20%) compared to Group II.
- The mean hospital stay was longer in Group I (5.76 days) than in Group II (4.40 days), with statistical significance (p<0.05).
Conclusions:
- Serum albumin levels below 3.50 gm/dL in patients with a first acute myocardial infarction are associated with an increased risk of adverse in-hospital outcomes.
- Lower serum albumin may serve as a valuable biomarker for predicting poor prognosis in AMI patients.
Abstract:
Acute myocardial infarction (AMI) patients constitute a large proportion of admissions in coronary care unit and their management and risk stratification is of immense importance. A decrease in serum albumin concentration might be associated with an increased risk in the incident of both cardiovascular diseases and worse hospital outcome. We assessed whether serum albumin levels at admission was associated with in-hospital adverse outcome in patients with first attack of acute myocardial infarction (AMI). The aim of the study was to evaluate association of serum albumin level with in-hospital outcome in patients with first attack of acute myocardial infarction. This cross-sectional analytical study was conducted in the department of cardiology in Mymensingh Medical College Hospital, Mymensingh, Bangladesh from March 2017 to February 2018. Total 374 patients of first attack of acute myocardial infarction included considering inclusion and exclusion criteria. The sample population was divided into two groups: Group I (Patients with acute myocardial infarction with serum albumin <3.5gm/dl) and. Group II (Patients with acute myocardial infarction with serum albumin ≥3.5gm/dl). Serum albumin level was measured within 24 hours of admission and the incidence of in-hospital major cardiac outcomes was observed. In this study mean±SD serum albumin level of Group I, Group II were 3.02±0.12gm/dl, 4.48±0.50gm/dl respectively. In Group I patient, 52(59.80%), 7(8.00%), 10(11.50%), developed heart failure, cardiogenic shock, arrhythmias respectively and 8(9.20%) died and in Group II patient 20(7.90%), 7(2.80%), 8(3.20%) developed heart failure, cardiogenic shock, arrhythmias respectively and 4(1.60%) died out of them and all of these outcome were statistically significant. Mean±SD duration of hospital stay of the study population according serum albumin level, in Group I, 5.76±1.83 days, in Group II, 4.40±1.22 days which was statistically significant (p<0.05). In conclusion, patient with first attack of acute myocardial infarction serum albumin level below 3.50gm/dl increased the risk of worse in-hospital outcome.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Serum Studies: Renal Function Tests
Acute Coronary Syndrome IV: Interprofessional Care
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...